Aurobindo Bets on Pen-G Integration and Biosimilars, but Revenue Impact Remains Distant

Strategic pivot toward API self-sufficiency and complex biologics is directionally sound, yet both initiatives are pre-commercial and contribute negligibly to consolidated revenue today.

bt-corporate · 6/28/2026, 9:33:39 AM · Ask about this →